Consolidated Statement Of Comprehensive Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7360123

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,787,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,517,000,000 JPY
14,446,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-63,000,000 JPY
-71,000,000 JPY
Deferred gains or losses on hedges
0 JPY
0 JPY
Foreign currency translation adjustment
147,000,000 JPY
68,000,000 JPY
Remeasurements of defined benefit plans, net of tax
11,000,000 JPY
0 JPY
Other comprehensive income
94,000,000 JPY
-3,000,000 JPY
Comprehensive income
3,881,000,000 JPY
14,514,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,834,000,000 JPY
14,483,000,000 JPY
Comprehensive income attributable to non-controlling interests
46,000,000 JPY
31,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.